脂质纳米颗粒信使RNA疫苗保护鱼类抵抗弹状病毒感染
本研究在虹鳟鱼中首次开展mRNA疫苗概念验证,使用脂质纳米颗粒(LNP)递送编码增强型绿色荧光蛋白(eGFP)的mRNA,在斑马鱼中实现长达7天的局部表达;编码病毒性出血性败血症病毒(VHSV)糖蛋白的LNP-mRNA候选疫苗诱导虹鳟产生中和抗体,并对致死性病毒攻击提供几乎完全保护。
要点
- LNP可高效递送mRNA至鱼类细胞且无明显毒性。
- 斑马鱼肌内注射LNP-eGFP mRNA后局部表达eGFP长达7天。
- LNP-mRNA VHSV糖蛋白疫苗诱导虹鳟中和抗体并几乎完全抵抗致死性攻击。
核心结论
- 研究首次在鱼类中证实mRNA疫苗接种可行,为水产养殖兽医疫苗开发开辟新途径。
研究设计与样本
- 概念验证研究:体外鱼类细胞实验、成年斑马鱼体内成像及虹鳟鱼疫苗接种与病毒攻击实验。
主要发现
- 体外实验显示LNP是鱼类细胞mRNA递送的有效载体且无明显毒性。
- 成年斑马鱼肌内注射LNP包裹的egfp mRNA后局部表达eGFP长达7天。
- 编码VHSV糖蛋白的LNP-mRNA候选疫苗在虹鳟中诱导中和抗体,并对致死性病毒攻击提供几乎完全保护。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
mRNA vaccines are poised to revolutionize disease prevention, following the approval of their administration to humans against SARS-CoV-2. Although they have been extensively studied for human applications, their potential in the veterinary field has not been explored yet. No mRNA vaccines have yet been reported for fish, despite the urgent need for new vaccines against emerging pathogens in aquaculture. As fish are ectotherms, temperature has an impact on their immune response and on many other biological parameters, including the composition of membrane lipids. It is therefore crucial to identify whether mRNA delivery systems are suitable for in vivo expression in fish for vaccine purposes. In the present study, we developed a proof of concept for mRNA vaccination in rainbow trout, a salmonid, demonstrating the efficacy of current vaccine delivery systems in fish. We used lipid nanoparticles (LNPs), which represent the most advanced delivery technology for mRNA. LNPs use a combination of lipid components that form an encapsulating structure offering protection and promote endosome escape of the mRNA to allow its expression. In vitro assays showed that LNPs are a powerful vehicle for mRNA delivery in fish cells without substantial toxicity. In vivo imaging in adult zebrafish (Danio rerio) demonstrated that intramuscular injection of LNP-formulated egfp mRNA resulted in local expression of eGFP for up to 7 days. An LNP-based mRNA vaccine candidate encoding the viral haemorrhagic septicaemia virus (VHSV) glycoprotein induced neutralizing antibodies in rainbow trout (Oncorhynchus mykiss) and offers almost complete protection against a lethal viral challenge. Our data constitute a first proof of concept of mRNA vaccination in fish, paving the way for new developments in veterinary vaccines for aquaculture.
引用
- Ayad C, Porter D, Lambert E, et al. An LNP-mRNA vaccine protects fish against rhabdovirus infection. Vaccine. 2025. PMID: 40031086. doi:10.1016/j.vaccine.2025.126957
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。